NCT06145932 Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor
| NCT ID | NCT06145932 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Soochow University |
| Condition | Essential Tremor |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-11-07 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-11-07 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the efficacy and electrophysiology of repetitive transcranial magnetic stimulation in the treatment of essential tremor.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed as essential tremor conforming to the diagnostic criteria for essential tremor in the tremor group of the International Parkinson's and Movement Disorders Society (IPMDS). 2. Signed informed consent form. Exclusion Criteria: 1. Complicated with brain organic diseases, epilepsy, other mental diseases, family history of dementia, metal devices implanted in the body and any contraindications to TMS; 2. History of craniocerebral surgery; 3. TMS cannot cooperate; 4. TMS-EEG examination artifacts are obvious, or cannot be analyzed due to other technical reasons.
Contact & Investigator
Chun-Feng Liu
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital of Soochow University
Frequently Asked Questions
Who can join the NCT06145932 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Essential Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06145932 currently recruiting?
Yes, NCT06145932 is actively recruiting participants. Contact the research team at liuchunfeng@suda.edu.cn for enrollment information.
Where is the NCT06145932 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06145932 clinical trial?
NCT06145932 is sponsored by Second Affiliated Hospital of Soochow University. The principal investigator is Chun-Feng Liu at Second Affiliated Hospital of Soochow University. The trial plans to enroll 40 participants.